Taiho Oncology, Inc. | Making the Human Connection

Features

Product Pipeline

Find out about the anti-cancer drugs we have in development

TAIHO ONCOLOGY, INC.

Learn more about our company history and overall mission

CULTURE

Hear first-hand what it is like to work at Taiho Oncology

Press Releases

REZILIENT3 Global First-Line Trial of Zipalertinib Launched in Patients With Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC)
Taiho Oncology and Servier Announce Publication in the New England Journal of Medicine of Pivotal Phase 3 Data for Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer

See how Taiho is making a difference in our community!

Our Initiatives

Job Postings

Considering a career at Taiho Oncology? Search our Job Board!